Trident Lifeline

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MKA01014
  • NSEID:
  • BSEID: 543616
INR
406.05
-3.95 (-0.96%)
BSENSE

Nov 20

BSE+NSE Vol: 10800

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
47.08
33.72
49.95
25.71
31.34
23.61
34.01
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
47.08
33.72
49.95
25.71
31.34
23.61
34.01
Raw Material Cost
7.76
11.99
13.43
17.47
18.30
11.78
19.20
Purchase of Finished goods
1.45
2.28
5.41
0.52
1.17
2.05
-2.31
(Increase) / Decrease In Stocks
18.19
6.02
14.52
-2.94
-1.33
-2.89
0.86
Employee Cost
3.06
1.69
2.19
2.53
3.38
2.68
3.94
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
0.00
0.00
0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
5.29
3.23
3.42
3.04
2.96
4.81
3.78
Total Expenditure (Excl Depreciation)
35.76
25.21
38.97
20.62
24.48
18.44
25.48
Operating Profit (PBDIT) excl Other Income
11.32
8.51
10.98
5.09
6.86
5.17
8.53
Other Income
0.97
0.57
1.62
4.63
1.67
1.35
1.87
Operating Profit (PBDIT)
12.29
9.08
12.60
9.72
8.53
6.52
10.40
Interest
1.93
0.86
0.77
1.24
0.99
1.13
1.55
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
10.36
8.22
11.83
8.48
7.54
5.39
8.85
Depreciation
1.56
1.62
1.23
2.46
0.91
1.46
2.74
Profit Before Tax
8.81
6.61
10.61
6.02
6.63
3.93
6.11
Tax
2.21
1.54
3.81
1.37
1.54
1.15
-0.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6.60
5.07
6.80
4.65
5.09
2.78
6.14
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6.60
5.07
6.80
4.65
5.09
2.78
6.14
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.04
0.07
0.34
0.14
-0.28
-0.93
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6.60
5.03
6.73
4.30
4.95
3.06
7.07
Equity Capital
11.59
11.93
11.93
11.93
11.60
11.50
11.50
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
5.69
4.22
5.64
3.6
4.27
2.66
6.15
Diluted Earnings per share
5.69
4.27
5.76
3.72
4.27
2.66
6.15
Operating Profit Margin (Excl OI)
24.04%
25.24%
21.98%
19.8%
21.89%
21.9%
25.08%
Gross Profit Margin
22.01%
24.38%
23.68%
32.98%
24.06%
22.83%
26.02%
PAT Margin
14.02%
15.04%
13.61%
18.09%
16.24%
11.77%
18.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 39.62% vs -32.49% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 31.21% vs -25.26% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 33.02% vs -22.50% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 124.42% vs 11.69% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Trident Lifeline With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
47.08
0
47.08
Other Operating Income
0.00
0.00
0.00
Total Operating income
47.08
0
47.08
Raw Material Cost
7.76
0
7.76
Purchase of Finished goods
1.45
0
1.45
(Increase) / Decrease In Stocks
18.19
0
18.19
Employee Cost
3.06
0
3.06
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
5.29
0.00
5.29
Total Expenditure (Excl Depreciation)
35.76
0
35.76
Operating Profit (PBDIT) excl Other Income
11.32
0.00
11.32
Other Income
0.97
0
0.97
Operating Profit (PBDIT)
12.29
0
12.29
Interest
1.93
0
1.93
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
10.36
0
10.36
Depreciation
1.56
0
1.56
Profit Before Tax
8.81
0
8.81
Tax
2.21
0
2.21
Provisions and contingencies
0.00
0
0.00
Profit After Tax
6.60
0
6.60
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
6.60
0
6.60
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.60
0
6.60
Equity Capital
11.59
0
11.59
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
5.69
0
5.69
Diluted Earnings per share
5.69
0
5.69
Operating Profit Margin (Excl OI)
24.04%
0%
0.00
24.04%
Gross Profit Margin
22.01%
0%
0.00
22.01%
PAT Margin
14.02%
0%
0.00
14.02%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 47.08 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 39.62% vs -32.49% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 50.22% vs 102.85% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.60 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 31.21% vs -25.26% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 33.33% vs 60.19% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.32 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 33.02% vs -22.50% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 65.01% vs 69.38% in Sep 2025

Quarterly - Interest
Interest 1.93 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 124.42% vs 11.69% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 94.95% vs 98.00% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.04%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025